AHA Coding Clinic® for HCPCS - 2015 Issue 4; For your information
Temporary HCPCS code for Alemutuzumab
Since October 1, 2015, a temporary HCPCS code was established for the reporting of Alemtuzumab (Lemtrada). Alemtuzumab (Lemtrada) is a monoclonal antibody utilized in treatment of patients with relapsing forms of multiple sclerosis. The temporary HCPCS code is listed in the table below. HCPCS codeHCPCS Long descriptorQ9979 Injection, alemtuzumab, 1 mg ...
Subscribe or sign in to view the full article.
Article Overview
This article covers a temporary HCPCS coding update related to alemtuzumab and provides context on the medication’s use in a neurological treatment setting. It is aimed at coders, billing staff, and other healthcare professionals who need to track HCPCS code changes and understand which types of services or medications are affected.
Why This Topic Matters
Temporary HCPCS updates can affect claim reporting and charge capture, so this article helps readers identify that a new reporting option exists and understand the general clinical context in which it appears.
What You Will Learn
- That a temporary HCPCS reporting update exists for alemtuzumab.
- The general clinical setting in which the medication is discussed.
- How a brief code update notice is typically presented in a coding reference article.
- Who may need to monitor temporary HCPCS changes.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Healthcare documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com